To what Extent are The Learnings from The Introduction of Biosimilars in Inflammatory Diseases Transferable to The Future Introduction of Biosimilars in Oncology?
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.2321
https://www.valueinhealthjournal.com/article/S1098-3015(16)33687-7/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2203
First Page :
A753
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33687-7&doi=10.1016/j.jval.2016.09.2321